Personal CFO Solutions LLC Has $344,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Personal CFO Solutions LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,007 shares of the medical equipment provider’s stock after selling 105 shares during the period. Personal CFO Solutions LLC’s holdings in Intuitive Surgical were worth $344,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Bank Julius Baer & Co. Ltd Zurich lifted its stake in shares of Intuitive Surgical by 99,583.4% in the 2nd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 643,694,311 shares of the medical equipment provider’s stock valued at $220,104,833,000 after purchasing an additional 643,048,572 shares during the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $915,360,000. Morgan Stanley raised its stake in shares of Intuitive Surgical by 29.9% in the 4th quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock valued at $1,556,706,000 after acquiring an additional 1,351,002 shares in the last quarter. Bank of Montreal Can acquired a new stake in Intuitive Surgical in the 2nd quarter worth approximately $294,657,000. Finally, Barclays PLC boosted its position in Intuitive Surgical by 159.5% during the second quarter. Barclays PLC now owns 1,379,246 shares of the medical equipment provider’s stock worth $471,619,000 after purchasing an additional 847,651 shares during the period. Institutional investors own 82.91% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $305.28 on Monday. The business’s fifty day moving average is $284.26 and its two-hundred day moving average is $305.11. The firm has a market cap of $107.48 billion, a P/E ratio of 71.83, a P/E/G ratio of 4.85 and a beta of 1.31. Intuitive Surgical, Inc. has a 52 week low of $222.65 and a 52 week high of $358.07.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.06. The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. Intuitive Surgical had a net margin of 22.14% and a return on equity of 12.91%. The firm’s quarterly revenue was up 12.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.90 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 4.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Royal Bank of Canada restated an “outperform” rating and issued a $355.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 20th. Wells Fargo & Company cut their target price on shares of Intuitive Surgical from $386.00 to $363.00 and set an “overweight” rating for the company in a research report on Friday, October 20th. TheStreet raised Intuitive Surgical from a “c+” rating to a “b” rating in a research report on Monday, July 24th. Barclays increased their target price on Intuitive Surgical from $314.00 to $385.00 and gave the company an “overweight” rating in a research note on Monday, July 24th. Finally, SVB Leerink started coverage on Intuitive Surgical in a research report on Monday, October 16th. They issued an “outperform” rating and a $342.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $342.71.

Insider Activity

In related news, EVP Robert Desantis sold 1,110 shares of the business’s stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $273.49, for a total value of $303,573.90. Following the completion of the transaction, the executive vice president now owns 7,259 shares in the company, valued at approximately $1,985,263.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Amy L. Ladd sold 500 shares of Intuitive Surgical stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $305.68, for a total value of $152,840.00. Following the completion of the sale, the director now directly owns 702 shares in the company, valued at $214,587.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 1,110 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $273.49, for a total transaction of $303,573.90. Following the transaction, the executive vice president now owns 7,259 shares in the company, valued at $1,985,263.91. The disclosure for this sale can be found here. Insiders have sold 55,208 shares of company stock valued at $15,275,529 over the last three months. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.